Wilson People Management Company Profile

01:00 EDT 20th September 2018 | BioPortfolio

WPM is a customer service business that specialises in the search and placement of contract and permanent OHS, Operational & HR professionals.Established in 2000 as Australia’s first dedicated HSE and HR search firm, WPM responded to an emerging need to provide a specialised service in this niche discipline. As a result, WPM has developed a strong understanding and industry networks throughout Australia with some of Australia’s largest organisations. WPM can offer an extensive range of candidates in these very specific disciplines. We invest time in gaining a detailed knowledge of of your organisation, its needs and culture and identify the actual competencies and skills required in a candidate to achieve your desired outcomes. We offer a discreet and confidential service to our clients and work hard to attract and recruit suitably qualified and experienced candidates accross Australia.


Level 1, 70 Pirie St


Phone: 61 8 8232 9997
Fax: 61 8 8232 9992

News Articles [1119 Associated News Articles listed on BioPortfolio]

GSK: Mark Wilson shares his enthusiasm about the need for challenge in the drug delivery space

In this episode of PharmaTelevision News Review, Fintan Walton talks to Mark Wilson, Director of Collaborative Management of GSK.

Alexion Purchases Wilson Therapeutics for $855M: Expands Pipeline

Alexion Pharmaceuticals is buying Wilson Therapeutics for $855 million. With the company, Alexion will acquire WTX101, Wilson Therapeutics’ Phase III compound for Wilson disease.

Wilson Therapeutics completes SEK244 directed share issue

Wilson Therapeutics AB (rare genetic disease treatments) raised SEK244 (28.9mm) through a directed share issue of 2.57mm ordinary shares at SEK95 (a 10% discount) to investors including Oppenheimer, S...

Alexion to Acquire Wilson Therapeutics and its Rare Liver Disorder Drug

NEW HAVEN, Conn.–(BUSINESS WIRE)–Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Wilson Therapeutics AB (publ) announced today that Alexion has made a recommended public cash offer to the ...

Alexion buys Wilson Therapeutics

Alexion Pharmaceuticals Inc. offered SEK232 ($27.84) per share to acquire Wilson Therapeutics AB, a Swedish biotech developing its sole candidate for the rare genetic condition Wilson disease. The dea...

Alexion bids $791m for rare disease biotech Wilson Therapeutics

Alexion Pharmaceuticals wants to buy Swedish rare diseases biotech Wilson Therapeutics for around $791 million, which is developing a late-stage drug to treat the inherited condition Wilson Disease. ...

Alexion bids $855m for rare disease biotech Wilson Therapeutics

Alexion wants to buy Swedish rare diseases biotech Wilson Therapeutics for around $855 million, which is developing a late-stage drug to treat the inherited condition Wilson Disease. In a statement W...

Nasdaq Stockholm AB: Observationsnoteringen för Wilson Therapeutics AB uppdateras / The observation status for Wilson Therapeutics AB is updated (89/18)

Den 11 april 2018 observationsnoterades aktierna i Wilson Therapeutics AB ("Bolaget") med hänvisning till ett offentligt uppköpserbjudande från Alexion Pharmaceuticals Inc., genom dess dotterbolag ...

PubMed Articles [3107 Associated PubMed Articles listed on BioPortfolio]

Anesthetic management of cesarean delivery for a parturient with Wilson's disease: A case report.

Wilson's disease (WD), or hepatolenticular degeneration, is an autosomal recessive disorder with a prevalence of 1:50,000 to 1:100,000 live births.

Getting better with age and time: A look back at the European experience for liver transplantation for pediatric patients with Wilson's disease.

Since the seminal experience of Starzl et al (1), liver transplant (LT) has been performed for Wilson's disease patients with failing livers and more controversially for neurologic disease. The major...

Barriers to effective diabetes management - a survey of people with severe mental illness.

People with severe mental illnesses (SMI) such as schizophrenia and bipolar disorder have an increased risk of developing type 2 diabetes and have poorer health outcomes than those with diabetes alone...

Dietary management of older people with diabetes.

Diabetes UK's revised nutrition guidelines for the prevention and management of diabetes, published recently, encourage education in self-management and include additional guidance for older people wi...

Supporting self-management for people with hypertension: a meta-review of quantitative and qualitative systematic reviews.

Globally, healthcare policy promotes supported self-management as a strategy for people with long-term conditions. This meta-review aimed to explore how people with hypertension make sense of their co...

Clinical Trials [5281 Associated Clinical Trials listed on BioPortfolio]

Study of Zinc for Wilson Disease

OBJECTIVES: I. Establish the safety and efficacy of extended maintenance zinc therapy in 200 patients with Wilson disease. II. Establish further the role of zinc in the prophylactic tre...

Efficacy and Safety,Long-Term Study of Zinc Acetate to Treat Wilson's Disease in Japan.

The purpose of this long-term study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.

Natural History of Wilson Disease

The purpose of the registry/repository is to provide a mechanism to store data and specimens to support the conduct of future research about Wilson disease (WD). The overall aim is to dete...

Study of Tetrathiomolybdate in Patients With Wilson Disease

OBJECTIVES: Evaluate the safety and efficacy of ammonium tetrathiomolybdate alone and compared with trientine therapy as initial treatment in patients with Wilson disease presenting ...

WILSTIM - DBS (WILson STIMulation - Deep Brain Stimulation)

Dystonia in Wilson's disease represent a major issue. The persistence of disabling motor symptoms despite medical treatments justifies conducting a study on deep brain stimulation (DBS) in...

Companies [2173 Associated Companies listed on BioPortfolio]

Wilson Elser Moskowitz Edelman & Dicker LLP

Wilson Elser Moskowitz Edelman & Dicker LLP is a full-service firm with clients in the United States, Latin America, Europe and Asia. Domestically, we rank among the American Lawyer 100 and The Natio...

Wilson Gunn

Wilson Gunn is one of the oldest and leading firms of Patent and Trade Mark Attorneys in the United Kingdom, with offices in Birmingham, London and Manchester.Our clients range from international corp...

Wilson Sonsini Goodrich & Rosati

Wilson Sonsini Goodrich & Rosati is the premier legal advisor to technology and growth enterprises worldwide, as well as the investment banks and venture capital firms that finance them. Over the past...

Wilson & Wilson Co., L.P.A.

The Wilson Group


More Information about "Wilson People Management" on BioPortfolio

We have published hundreds of Wilson People Management news stories on BioPortfolio along with dozens of Wilson People Management Clinical Trials and PubMed Articles about Wilson People Management for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Wilson People Management Companies in our database. You can also find out about relevant Wilson People Management Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record